8. Conclusion
Clinical trials are valuable in both advancing the scientific knowledge of surgical oncology and defining the very best care for patients afflicted by malignancies. As an obligation to both the scientific community and the general public, the cooperative audit programs and the CTMB collaborate to ensure that the conduct of clinical trials are meticulous and the data are validated. However, audit programs should be viewed not merely as a surveillance mechanism. It serves as a stimulus for performance improvement by providing opportunities for peer-review and education.
Supported by the Ruth L. Kirschstein National Research Service Awards Training Grant T32CA101695 and the American College of Surgeons Oncology Group Grant U10CA76001, both from the National Cancer Institute.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Knatterud, G.L., F.W. Rockhold, S.L. George, et al., Guidelines for quality assurance in multicenter trials: a position paper. Control Clin Trials, 19(5), 477–93 (1998).
CTEP NCI Guidelines: Monitoring of clinical trials. http://ctep.cancer.gov/monitoring.
Califf, R.M., S.L. Karnash, and L.H. Woodlief, Developing systems for cost-effective auditing of clinical trials. Control Clin Trials. 18(6), 651–60; discussion 661–6 (1997).
Mauer, J.K., D.F. Hoth, D.K. MacFarlane, et al., Site visit monitoring program of the clinical cooperative groups: results of the first 3 years. Cancer Treat Rep. 69(10), 1177–87 (1985).
The American College of Surgeons Oncology Group (ACOSOG). The audit manual. 2004.
Ota, D., The audit program of the American College of Surgeons Oncology Group. American College of Surgeons 89th Clinical Congress post graduate course. 2003.
Morse, M.A., R.M. Califf, and J. Sugarman, Monitoring and ensuring safety during clinical research. JAMA. 285(9), 1201–5 (2001).
Siden, R., R.M. Tankanow, and H.R. Tamer, Understanding and preparing for clinical drug trial audits. Am J Health-Syst Pharm. 59(25), 2305–6 (2002).
CTEP NCI guidelines: Adverse event reporting requirements. http://ctep.cancer.gov/reporting/newadverse_2005.pdf.
Mason, S., J. Nicholl, and R. Lilford, What to do about poor clinical performance in clinical trials. BMJ. 324(7334), 419–20 (2002).
Weiss, R.B., N.J. Vogelzang, B.A. Peterson, et al., A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B. JAMA. 270(4), 459–64 (1993).
Sunderland, M., S Kuebler, G Weiss, et al., Compliance with protocol: quality assurance (QA) data from the Southwestern Oncology Group (SWOG). Proc Am Soc Clin Oncol. 9, 60 (1990).
Fisher, B. and C.K. Redmond, Fraud in breast-cancer trials. N Engl J Med. 330(20), 1458–60 (1994).
Christian, M.C., M.S. McCabe, E.L. Korn, et al., The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. N Engl J Med. 333(22), 1469–74 (1995).
McCulloch, P., I Taylor, M Sasako, et al., Randomised trials in surgery: problems and possible solutions. BMJ. 324(7351), 1448–51 (2002).
Therasse, P. and A.M. Eggermont, Research and quality control in surgical oncology. Surg Oncol Clin N Am. 10(4), 763–72, viii (2001).
Bourez, R.L. and E.J. Rutgers, The European Organization for Research and Treatment of Cancer (EORTC) Breast Cancer Group: quality control of surgical trials. Surg Oncol Clin N Am. 10(4), 807–19, ix (2001).
Hjorth, M., E. Holmberg, S. Rodjer, et al., Patient accrual and quality of participation in a multicentre study on myeloma: a comparison between major and minor participating centres. Br J Haematol, 91(1), 109–15 (1995).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
You, Y.N., Jacobs, L., Martinez, E., Ota, D.M. (2007). The Audit Process and How to Ensure a Successful Audit. In: Leong, S.P.L. (eds) Cancer Clinical Trials: Proactive Strategies. Cancer Treatment and Research, vol 132. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-33225-3_9
Download citation
DOI: https://doi.org/10.1007/978-0-387-33225-3_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-33224-6
Online ISBN: 978-0-387-33225-3
eBook Packages: MedicineMedicine (R0)